Minocycline topical - Hovione

Drug Profile

Minocycline topical - Hovione

Alternative Names: HY01; HY01 Topical Gel

Latest Information Update: 20 Dec 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Hovione
  • Class Amides; Anti-inflammatories; Antibacterials; Dimethylamines; Neuroprotectants; Small molecules; Tetracyclines
  • Mechanism of Action Protein 30S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Rosacea
  • Preclinical Acne

Most Recent Events

  • 13 Dec 2017 Phase-II MARS clinical trials in Rosacea in USA (Topical) (NCT03263273)
  • 30 Aug 2017 Hovione Scientia plans a phase II trial for Papulopustular rosacea in USA (Topical, Gel), in September 2017 (NCT03263273)
  • 27 Nov 2014 Preclinical trials in Acne in Ireland before November 2014 (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top